Midostaurin (PKC412), an oral multi-kinase inhibitor of PKCalpha, beta, and gamma isoforms and AKT, as well as of the TK receptors PDGFR, VEGFR, and FLT3, is known to induce apoptosis in human myeloma cells ([170]. The gene discussed is FLT3; the disease is plasma cell myeloma.